Biocon shares in focus after US FDA nod for key cancer drugs 0 05.03.2025 06:45 Economictimes.indiatimes.com Biocon share price: The company also received tentative FDA approval for its ANDA for Rivaroxaban, an anticoagulant used to treat deep vein thrombosis, pulmonary embolism, and reduce stroke risk in nonvalvular atrial fibrillation. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
